Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads.

AIMS Serious concerns have been recently raised about the reliability of the silicone-polyurethane copolymer (Optim™) lead insulation system. We sought to identify insulation defects and Optim-lead failures by systematic fluoroscopic and electrical assessment in a prospectively defined cohort of implantable cardioverter-defibrillator (ICD) patients. METHODS AND RESULTS Between July 2007 and December 2011, 234 patients were implanted with 413 optim-coated leads as part of an ICD system at a single centre. Fluoroscopic screening with high-resolution cine-fluoroscopy at 30 frames per second was offered to all patients. In addition, the electrical integrity of all implanted leads was assessed. Durata, Riata ST Optim, and low-voltage Optim leads were implanted in 199, 26, and 188 cases, respectively. During a total follow-up of 10 036 lead-months, there were 7 Optim-lead failures (defined as electrical malfunction resulting in lead replacement) and 31 deaths; no cases of electrical noises were encountered. The overall incidence of lead failure was 1.2 vs. 0.3 per 100 lead-years, for high- and low-voltage leads, respectively (P = 0.1). One hundred fifty-one patients agreed to undergo fluoroscopy screening; none of the 264 analysed Optim leads were found to have any fluoroscopically visible structural defects after an average of 31 months post-implant. CONCLUSION This study represents the first systematic screening of Optim-coated leads in a large unselected cohort of ICD patients. Over a 5-year period few lead failures were observed and normal fluoroscopic appearance was present in all patients.

[1]  H. Tanner,et al.  Prevalence of asymptomatic and electrically undetectable intracardiac inside-out abrasion in silicon-coated Riata® and Riata® ST implantable cardioverter-defibrillator leads. , 2013, International journal of cardiology.

[2]  S. Saba,et al.  Failure-free survival of the Durata defibrillator lead. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  J. Brinker,et al.  Abrasion of a DF‐4 Defibrillator Lead , 2013, Journal of cardiovascular electrophysiology.

[4]  Andrew S. Mugglin,et al.  Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads. , 2013, Heart rhythm.

[5]  L. Poggio,et al.  Failure of implantable cardioverter-defibrillator leads: a matter of lead size? , 2013, Heart rhythm.

[6]  R. Hauser,et al.  Failure of a novel silicone–polyurethane copolymer (Optim™) to prevent implantable cardioverter-defibrillator lead insulation abrasions , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  J. R. Moorman,et al.  Increasing lead burden correlates with externalized cables during systematic fluoroscopic screening of Riata leads , 2013, Journal of Interventional Cardiac Electrophysiology.

[8]  R. Noad,et al.  Fluoroscopic and Electrical Assessment of a Series of Defibrillation Leads: Prevalence of Externalized Conductors , 2012, Pacing and clinical electrophysiology : PACE.

[9]  A. Elvan,et al.  Prevalence and Presentation of Externalized Conductors and Electrical Abnormalities in Riata Defibrillator Leads After Fluoroscopic Screening: Report From the Netherlands Heart Rhythm Association Device Advisory Committee , 2012, Circulation. Arrhythmia and electrophysiology.

[10]  Marc A. Hillmyer,et al.  Influence of water on the structure and properties of PDMS-containing multiblock polyurethanes , 2012 .

[11]  A. Natale,et al.  Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. , 2012, Heart rhythm.

[12]  Christopher R. Ellis,et al.  High prevalence of insulation failure with externalized cables in St. Jude Medical Riata family ICD leads: fluoroscopic grading scale and correlation to extracted leads. , 2012, Heart rhythm.

[13]  R. Hauser,et al.  Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. , 2012, Heart rhythm.

[14]  S. Saba,et al.  Fluoroscopic Screening of Asymptomatic Patients Implanted With the Recalled Riata Lead Family , 2012, Circulation. Arrhythmia and electrophysiology.

[15]  S. Hohnloser,et al.  Insulation Defects of Thin High‐Voltage ICD Leads: , 2011, Journal of cardiovascular electrophysiology.

[16]  H. Calkins,et al.  Premature Failure of a Riata Defibrillator Lead Without Impedance Change or Inappropriate Sensing: A Case Report and Review of the Literature , 2011, Journal of cardiovascular electrophysiology.

[17]  Acc Aha Esc [ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden death]. , 2011, Kardiologiia.

[18]  G. Hindricks,et al.  Clinical Performance of the St. Jude Medical Riata Defibrillation Lead in a Large Patient Population , 2010, Journal of cardiovascular electrophysiology.

[19]  S. Greenberg,et al.  Performance of the St. Jude Medical Riata leads. , 2009, Heart rhythm.

[20]  C. Israel,et al.  Implantable cardioverter-defibrillator lead disintegration at the level of the tricuspid valve. , 2008, Heart rhythm.

[21]  Kent R Nilsson,et al.  Early failure of a small diameter high-voltage implantable cardioverter-defibrillator lead. , 2008, Heart rhythm.

[22]  Thomas Kleemann,et al.  Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years , 2007, Circulation.

[23]  C. Jenney,et al.  A new insulation material for cardiac leads with potential for improved performance , 2005 .

[24]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[25]  Wojciech Zareba,et al.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. , 2002, The New England journal of medicine.